| P2093 | author name string | Abdul Samad | |
| | Padma V. Devarajan | |
| | Rajiv V. Gaikwad | |
| | Swati A. Guhagarkar | |
| | Vinod C. Malshe | |
| P2860 | cites work | Doxorubicin-induced cardiomyopathy | Q77323607 |
| | How to concentrate nanoparticles and avoid aggregation? | Q81038789 |
| | Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles | Q93944406 |
| | Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: A technical note | Q95764061 |
| | Hepatocellular carcinoma | Q29615841 |
| | Conjugates of poly(DL-lactide-co-glycolide) on amino cyclodextrins and their nanoparticles as protein delivery system. | Q30356721 |
| | Busulfan loading into poly(alkyl cyanoacrylate) nanoparticles: physico-chemistry and molecular modeling | Q31056150 |
| | Evidence for receptor-mediated hepatic uptake of pullulan in rats | Q31966526 |
| | Nanoparticles in cancer therapy and diagnosis | Q34804817 |
| | Nanoparticles for drug delivery: review of the formulation and process difficulties illustrated by the emulsion-diffusion process | Q36627048 |
| | Freeze-drying of nanoparticles: formulation, process and storage considerations | Q36659686 |
| | Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles | Q36833069 |
| | Engineered nanocarriers of doxorubicin: a current update | Q37186741 |
| | Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies | Q37361729 |
| | Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers | Q38548137 |
| | Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin | Q39858356 |
| | Freeze thaw: a simple approach for prediction of optimal cryoprotectant for freeze drying | Q39923763 |
| | The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma | Q39929948 |
| | A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells | Q40265140 |
| | Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor. | Q40822661 |
| | Nanoparticles of polyethylene sebacate: a new biodegradable polymer | Q41916300 |
| | Acute renal toxicity of doxorubicin (adriamycin)-loaded cyanoacrylate nanoparticles | Q42278744 |
| | Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes | Q42824677 |
| | In vitro gene delivery to hepatocytes with galactosylated polyethylenimine | Q42833898 |
| | Liver targeting of plasmid DNA by pullulan conjugation based on metal coordination | Q44167837 |
| | Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers | Q44965493 |
| | Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes | Q45857706 |
| | Polyethylene sebacate: genotoxicity, mutagenicity evaluation and application in periodontal drug delivery system. | Q46004495 |
| | Development and evaluation of novel itraconazole-loaded intravenous nanoparticles | Q46514346 |
| | Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin | Q46754852 |
| | Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs | Q47225839 |
| | Polymer-surfactant nanoparticles for sustained release of water-soluble drugs. | Q50465664 |
| | Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. | Q51466557 |
| | PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. | Q51475804 |
| | Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles | Q57133920 |
| | Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): Drug release behavior and stability in the presence of serum | Q57352470 |
| | Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods | Q57922188 |
| | Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation | Q60775226 |
| | Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice | Q70474850 |
| | Prevention of chronic doxorubicin cardiotoxicity in beagles by liposomal encapsulation | Q71030236 |
| | Uptake of nanoparticles by rat glomerular mesangial cells in vivo and in vitro | Q72834298 |
| | In vivo gene delivery to the liver using novel galactosylated cationic liposomes | Q73761281 |
| P433 | issue | 1-2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| P304 | page(s) | 113-122 | |
| P577 | publication date | 2010-09-18 | |
| P1433 | published in | International Journal of Pharmaceutics | Q6051539 |
| P1476 | title | Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting | |
| | Polyethylene sebacate–doxorubicin nanoparticles for hepatic targeting | |
| P478 | volume | 401 | |